Citius pharmaceuticals to participate in upcoming ef hutton and h.c. wainwright investor conferences

Cranford, n.j. , may 10, 2024 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in two upcoming investor conferences.

CTXR Ratings Summary

CTXR Quant Ranking